DK382889A - Konjugater af antistoffer og cytotoxiske methotrexat-forbindelser og fremgangsmaade til fremstilling af saadanne konjugater - Google Patents
Konjugater af antistoffer og cytotoxiske methotrexat-forbindelser og fremgangsmaade til fremstilling af saadanne konjugater Download PDFInfo
- Publication number
- DK382889A DK382889A DK382889A DK382889A DK382889A DK 382889 A DK382889 A DK 382889A DK 382889 A DK382889 A DK 382889A DK 382889 A DK382889 A DK 382889A DK 382889 A DK382889 A DK 382889A
- Authority
- DK
- Denmark
- Prior art keywords
- conjugates
- methotrexate
- cytotoxic
- antibodies
- procedures
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/44—Antibodies bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6883—Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/229,941 US5028697A (en) | 1988-08-08 | 1988-08-08 | Cytotoxic antibody conjugates of hydrazide derivatized methotrexate analogs via simple organic linkers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK382889D0 DK382889D0 (da) | 1989-08-04 |
| DK382889A true DK382889A (da) | 1990-02-09 |
Family
ID=22863313
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK382889A DK382889A (da) | 1988-08-08 | 1989-08-04 | Konjugater af antistoffer og cytotoxiske methotrexat-forbindelser og fremgangsmaade til fremstilling af saadanne konjugater |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5028697A (fr) |
| EP (1) | EP0354729B1 (fr) |
| JP (1) | JPH02256700A (fr) |
| KR (1) | KR900002803A (fr) |
| CN (1) | CN1040204A (fr) |
| AU (1) | AU619328B2 (fr) |
| DE (1) | DE68912232T2 (fr) |
| DK (1) | DK382889A (fr) |
| HU (1) | HU208161B (fr) |
| IL (1) | IL91181A0 (fr) |
| MX (1) | MX165003B (fr) |
| NZ (1) | NZ230199A (fr) |
| PT (1) | PT91371B (fr) |
| ZA (1) | ZA895909B (fr) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5010176A (en) * | 1988-11-10 | 1991-04-23 | Eli Lilly And Company | Antibody-drug conjugates |
| US5977307A (en) * | 1989-09-07 | 1999-11-02 | Alkermes, Inc. | Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins |
| US6329508B1 (en) | 1989-09-07 | 2001-12-11 | Alkermes, Inc. | Transferrin receptor reactive chimeric antibodies |
| US5672683A (en) * | 1989-09-07 | 1997-09-30 | Alkermes, Inc. | Transferrin neuropharmaceutical agent fusion protein |
| ZA914625B (en) * | 1990-06-22 | 1993-02-24 | Lilly Co Eli | In vivo targeting with bifunctional antibodies |
| US5272253A (en) * | 1991-07-01 | 1993-12-21 | Eli Lilly And Company | Cluster conjugates of drugs with antibodies |
| GR1001459B (el) * | 1992-10-08 | 1993-12-30 | Lilly Co Eli | Σύμπλεγμα συζυγών φαρμάκων με αντισώματα. |
| US5382582A (en) * | 1993-03-26 | 1995-01-17 | Chan; Carcy L. | Methotrexate analogs and methods of using same |
| US5556623A (en) * | 1993-03-30 | 1996-09-17 | Eli Lilly And Company | Antibody-drug conjugates |
| JPH072895A (ja) * | 1993-04-28 | 1995-01-06 | Eli Lilly & Co | 抗体−薬物複合体 |
| US5773001A (en) * | 1994-06-03 | 1998-06-30 | American Cyanamid Company | Conjugates of methyltrithio antitumor agents and intermediates for their synthesis |
| US6015555A (en) * | 1995-05-19 | 2000-01-18 | Alkermes, Inc. | Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates |
| US5714586A (en) * | 1995-06-07 | 1998-02-03 | American Cyanamid Company | Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates |
| US5712374A (en) * | 1995-06-07 | 1998-01-27 | American Cyanamid Company | Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates |
| US5698556A (en) * | 1995-06-07 | 1997-12-16 | Chan; Carcy L. | Methotrexate analogs and methods of using same |
| US20030119724A1 (en) * | 1995-11-22 | 2003-06-26 | Ts`O Paul O.P. | Ligands to enhance cellular uptake of biomolecules |
| AU2002217980A1 (en) | 2000-12-01 | 2002-06-11 | Cell Works Inc. | Conjugates of glycosylated/galactosylated peptide |
| DK2163256T3 (en) | 2001-05-11 | 2015-12-07 | Ludwig Inst For Cancer Res Ltd | Specific binding proteins and use thereof |
| US20100056762A1 (en) | 2001-05-11 | 2010-03-04 | Old Lloyd J | Specific binding proteins and uses thereof |
| JP4903036B2 (ja) * | 2003-01-06 | 2012-03-21 | アンジオケム・インコーポレーテッド | 血液脳関門を通過する担体としてのアプロチニンおよび類似体 |
| US20080312201A1 (en) * | 2004-09-10 | 2008-12-18 | Patrick Fogarty | Reduced Toxicity Methotrexate Formulations and Methods for Using the Same |
| US20090016959A1 (en) * | 2005-02-18 | 2009-01-15 | Richard Beliveau | Delivery of antibodies to the central nervous system |
| DK2360258T3 (en) * | 2005-02-18 | 2015-01-12 | Angiochem Inc | Aprotininpolypeptider to transport a compound of blood-brain-barrier |
| EP1907009A4 (fr) | 2005-07-15 | 2009-09-02 | Angiochem Inc | Utilisation de polypeptides de l'aprotinine comme vehicules dans des conjugues pharmaceutiques |
| ES2473665T3 (es) | 2005-11-28 | 2014-07-07 | Verrow Pharmaceuticals, Inc. | Composiciones útiles para reducir la nefrotoxicidad y los métodos de uso de las mismas |
| ES2609094T3 (es) | 2007-01-25 | 2017-04-18 | Dana-Farber Cancer Institute, Inc. | Uso de anticuerpos anti-EGFR en el tratamiento de enfermedades mediadas por un EGFR mutante |
| CN101688229B (zh) | 2007-03-15 | 2013-06-12 | 路德维格癌症研究所 | 包含egfr抗体和src抑制剂的组合物及其在制备用于治疗哺乳动物癌症的药物中的用途 |
| US9365634B2 (en) * | 2007-05-29 | 2016-06-14 | Angiochem Inc. | Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues |
| US9283276B2 (en) | 2007-08-14 | 2016-03-15 | Ludwig Institute For Cancer Research Ltd. | Monoclonal antibody 175 targeting the EGF receptor and derivatives and uses thereof |
| CA2729613C (fr) | 2008-03-03 | 2017-02-07 | Tosk, Incorporated | Adjuvants pour reduire la toxicite du methotrexate, et procedes d'utilisation |
| DK2279008T3 (en) * | 2008-04-18 | 2019-04-29 | Angiochem Inc | PHARMACEUTICAL COMPOSITIONS OF PACLITAXEL, PACLITAXEL ANALOGS OR PACLITAXEL CONJUGATES AND RELATED PROCEDURES FOR PREPARATION AND USE |
| CN102245642A (zh) | 2008-10-15 | 2011-11-16 | 安吉奥开米公司 | Glp-1激动剂的结合物及其用途 |
| RU2531591C2 (ru) | 2008-10-15 | 2014-10-20 | Ангиокем Инк. | Конъюгаты этопозида и доксорубицина для доставки лекарственных средств |
| AU2009322043A1 (en) * | 2008-12-05 | 2011-07-07 | Angiochem Inc. | Conjugates of neurotensin or neurotensin analogs and uses thereof |
| BRPI0922611A2 (pt) | 2008-12-17 | 2018-11-06 | Angiochem Inc | inibidores de metaloproteína de matriz de membrana tipo 1 e usos dos mesmos |
| CA2759129C (fr) | 2009-04-20 | 2018-12-11 | Angiochem Inc. | Traitement d'un cancer de l'ovaire a l'aide d'un agent anticancereux conjugue a un analogue d'angiopep-2 |
| US9161988B2 (en) | 2009-07-02 | 2015-10-20 | Angiochem Inc. | Multimeric peptide conjugates and uses thereof |
| RU2674036C2 (ru) | 2011-05-16 | 2018-12-04 | Джензим Корпорейшн | Индукция иммунологической толерантности, используя метотрексат |
| SG11201507619PA (en) | 2013-03-15 | 2015-10-29 | Ct For Drug Res And Dev | Cytotoxic and anti-mitotic compounds, and methods of using the same |
| WO2015095953A1 (fr) | 2013-12-27 | 2015-07-02 | The Centre For Drug Research And Development | Systèmes de liaison contenant un sulfonamide pour conjugués de médicaments |
| CN107001415B (zh) | 2014-09-17 | 2021-06-18 | 酵活有限公司 | 细胞毒性和抗有丝分裂化合物、及其使用方法 |
| DK3307326T3 (da) | 2015-06-15 | 2020-10-19 | Angiochem Inc | Fremgangsmåder til behandling af leptomeningeal karcinomatose |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI820020L (fi) * | 1981-01-12 | 1982-07-13 | Lilly Industries Ltd | Immunoglobulinkonjugater |
| US4631190A (en) * | 1981-06-26 | 1986-12-23 | Shen Wei C | Acidity-sensitive spacer molecule to control the release of pharmaceuticals from molecular carriers |
| EP0083367A1 (fr) * | 1981-07-02 | 1983-07-13 | WALTON, Alan G. | Complexe medicamenteux de glycosaminoglycan |
| CA1203164A (fr) * | 1982-03-09 | 1986-04-15 | Thomas J. Mckearn | Conjugats d'anticorps |
| US4671958A (en) * | 1982-03-09 | 1987-06-09 | Cytogen Corporation | Antibody conjugates for the delivery of compounds to target sites |
| EP0121388B1 (fr) * | 1983-03-30 | 1990-06-13 | Lilly Industries Limited | Conjugués d'immunoglobuline |
| US4699784A (en) * | 1986-02-25 | 1987-10-13 | Center For Molecular Medicine & Immunology | Tumoricidal methotrexate-antibody conjugate |
| GB8610551D0 (en) * | 1986-04-30 | 1986-06-04 | Hoffmann La Roche | Polypeptide & protein derivatives |
| CA1330378C (fr) * | 1986-05-08 | 1994-06-21 | Daniel J. Coughlin | Derives amine d'analogues de l'acide folique |
| US4997913A (en) * | 1986-06-30 | 1991-03-05 | Oncogen | pH-sensitive immunoconjugates and methods for their use in tumor therapy |
| WO1988001513A1 (fr) * | 1986-08-28 | 1988-03-10 | Teijin Limited | Complexe d'anticorps cytocide et procede de production |
| IE63869B1 (en) * | 1986-11-06 | 1995-06-14 | Res Dev Foundation | Aerosols containing liposomes and method for their preparation |
| US4918165A (en) * | 1987-07-16 | 1990-04-17 | Ophthalmic Research Corporation | Mitotic inhibitor and method for preventing posterior lens capsule opacification after extracapsular extraction |
-
1988
- 1988-08-08 US US07/229,941 patent/US5028697A/en not_active Expired - Fee Related
-
1989
- 1989-08-02 IL IL91181A patent/IL91181A0/xx unknown
- 1989-08-02 ZA ZA895909A patent/ZA895909B/xx unknown
- 1989-08-03 NZ NZ230199A patent/NZ230199A/xx unknown
- 1989-08-03 EP EP89307916A patent/EP0354729B1/fr not_active Expired - Lifetime
- 1989-08-03 DE DE68912232T patent/DE68912232T2/de not_active Expired - Fee Related
- 1989-08-03 PT PT91371A patent/PT91371B/pt not_active IP Right Cessation
- 1989-08-04 MX MX17078A patent/MX165003B/es unknown
- 1989-08-04 DK DK382889A patent/DK382889A/da not_active Application Discontinuation
- 1989-08-04 AU AU39338/89A patent/AU619328B2/en not_active Ceased
- 1989-08-07 JP JP1205544A patent/JPH02256700A/ja active Pending
- 1989-08-07 KR KR1019890011216A patent/KR900002803A/ko not_active Application Discontinuation
- 1989-08-07 CN CN89106471A patent/CN1040204A/zh active Pending
- 1989-08-07 HU HU893993A patent/HU208161B/hu not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0354729A3 (fr) | 1991-04-17 |
| AU3933889A (en) | 1990-02-08 |
| DE68912232D1 (de) | 1994-02-24 |
| HUT50850A (en) | 1990-03-28 |
| EP0354729B1 (fr) | 1994-01-12 |
| HU208161B (en) | 1993-08-30 |
| US5028697A (en) | 1991-07-02 |
| AU619328B2 (en) | 1992-01-23 |
| KR900002803A (ko) | 1990-03-23 |
| DE68912232T2 (de) | 1994-05-19 |
| ZA895909B (en) | 1991-04-24 |
| PT91371B (pt) | 1995-05-04 |
| JPH02256700A (ja) | 1990-10-17 |
| IL91181A0 (en) | 1990-03-19 |
| DK382889D0 (da) | 1989-08-04 |
| CN1040204A (zh) | 1990-03-07 |
| MX165003B (es) | 1992-10-13 |
| NZ230199A (en) | 1991-09-25 |
| EP0354729A2 (fr) | 1990-02-14 |
| PT91371A (pt) | 1990-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK382889A (da) | Konjugater af antistoffer og cytotoxiske methotrexat-forbindelser og fremgangsmaade til fremstilling af saadanne konjugater | |
| DK612789D0 (da) | Fremgangsmaade til fremstilling af pyridinderivater | |
| DK640989D0 (da) | Mikrobiologisk fremgangsmaade til fremstilling af immunundertrykkende antibiotika | |
| DK556689D0 (da) | Antistof-konjugater, fremgangsmaade til fremstilling heraf og farmaceutiske midler indeholdende disse | |
| DK581688A (da) | L-tyrosinderivater og fremgangsmaade til fremstilling af samme | |
| DK4189A (da) | Oxadiazolforbindelse, farmaceutisk praeparat indeholdende og fremgangsmaade til fremstilling af forbindelsen | |
| DK250689A (da) | Fremgangsmaade til fremstilling af napthalenderivater | |
| DK665489A (da) | Fremgangsmaade til fremstilling af mono-n-alkylerede polyazamakrocykliske forbindelser | |
| DK102990D0 (da) | Thieno-triazolodiazepinderivater, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse | |
| DK30489A (da) | Fremgangsmaade til fremstilling af pyranderivater | |
| PT86960A (pt) | Process for the preparation of immunoglobulin conjugates | |
| DK635988D0 (da) | 1,3-butandiolacetoacetat-derivater og anvendelse af 1,3-butandiolacetoacetat-forbindelser til fremstilling af farmaceutiske praeparater | |
| DK115291A (da) | Fremgangsmaade til fremstilling af amfotere overfladeaktive imidazolinderivater | |
| DK601489D0 (da) | Fremgangsmaade til fremstilling af alkansulfonamider | |
| DK32989A (da) | Immunoglobulin-konjugater og fremgangsmaade til fremstilling deraf | |
| DK0458855T3 (da) | Farmaceutisk præparat til behandling af tonsillitis | |
| DK314988A (da) | Fremgangsmaade til fremstilling af 6-deoxyguaninderivater | |
| DK291189D0 (da) | Kondenserede diazepinoner, fremgangsmaade til fremstilling af saadanne forbindelser og laegemidler med indhold af forbindelserne | |
| DK28788D0 (da) | Fremgangsmaade til fremstilling af alkansulfonamider | |
| DK113189D0 (da) | Fremgangsmaade til fremstilling af pyridinderivater | |
| DK143889A (da) | Fremgangsmaade til fremstilling af naphthalenderivater | |
| DK97388D0 (da) | Mellemprodukt og fremgangsmaade til fremstilling af antihypercholestrolemiske tetrazolforbindelser | |
| DK231990A (da) | Fremgangsmaade til fremstilling af emballagevaeg | |
| DK293589D0 (da) | Fremgangsmaade til fremstiling af lactolderivater | |
| DK100392D0 (da) | 3- og 5-substituerede 1,2,3,4-oxatriazol-5-iminforbindelser og fremgangsmaade til fremstilling deraf, farmaceutisk praeparat indeholdende disse forbindelser samt forbindelsernes anvendelse til fremstilling af laegemidler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment |